EcoDrugPlus

Ensembl ID : ML120721a
Gene Symbol: -
External references: -
88 Possible Orthologues:

Ensembl ID : ML12235a
Gene Symbol: -
External references: -
1060 Possible Orthologues:

Ensembl ID : ML123611a
Gene Symbol: -
External references: -
548 Possible Orthologues:

Ensembl ID : ML12551a
Gene Symbol: -
External references: -
278 Possible Orthologues:

Ensembl ID : ML12811a
Gene Symbol: -
External references: -
241 Possible Orthologues:

Ensembl ID : ML128219a
Gene Symbol: -
External references: -
194 Possible Orthologues:

Ensembl ID : ML128225a
Gene Symbol: -
External references: -
93 Possible Orthologues:

Ensembl ID : ML13052a
Gene Symbol: -
External references: -
65 Possible Orthologues:

Ensembl ID : ML131110a
Gene Symbol: -
External references: -
32 Possible Orthologues:

Ensembl ID : ML13145a
Gene Symbol: -
External references: -
260 Possible Orthologues:

Ensembl ID : ML13166a
Gene Symbol: -
External references: -
75 Possible Orthologues:

Ensembl ID : ML13373a
Gene Symbol: -
External references: -
117 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).